Better Therapeutics Statistics Share Statistics Better Therapeutics has 54.52M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 54.52M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.01% Shares Floating 25.69M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.13M, so undefined% of the outstanding
shares have been sold short.
Short Interest 2.13M Short % of Shares Out n/a Short % of Float 8.68% Short Ratio (days to cover) 0.94
Valuation Ratios The PE ratio is -0.66 and the forward
PE ratio is null.
Better Therapeutics's PEG ratio is
0.56.
PE Ratio -0.66 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -29.09 P/FCF Ratio -0.87 PEG Ratio 0.56
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Better Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.37,
with a Debt / Equity ratio of -16.55.
Current Ratio 1.37 Quick Ratio 1.37 Debt / Equity -16.55 Debt / EBITDA -0.39 Debt / FCF -0.49 Interest Coverage -25.66
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-736.3K Employee Count 54 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 7K Effective Tax Rate -0.02%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 1.69, so Better Therapeutics's
price volatility has been higher than the market average.
Beta 1.69 52-Week Price Change n/a 50-Day Moving Average 0 200-Day Moving Average 0 Relative Strength Index (RSI) 63.59 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit -2.73M Operating Income -38.26M Net Income -39.76M EBITDA -38.26M EBIT n/a Earnings Per Share (EPS) -1.69
Full Income Statement Balance Sheet The company has 15.74M in cash and 14.88M in
debt, giving a net cash position of 860K.
Cash & Cash Equivalents 15.74M Total Debt 14.88M Net Cash 860K Retained Earnings -111.5M Total Assets 10.72M Working Capital -5.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -28.93M
and capital expenditures -1.18M, giving a free cash flow of -30.11M.
Operating Cash Flow -28.93M Capital Expenditures -1.18M Free Cash Flow -30.11M FCF Per Share -1.28
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
